Objective. The aim of this study was to compare baseline variables, treatment and outcomes
in patients with large-vessel GCA (LV-GCA), primarily of the upper extremities, with those …

Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could
be challenging since there is not one single test able to achieve an accurate diagnosis. The …

We reviewed 888 temporal artery biopsies (TAB) performed in 871 patients in a single institution
from January 1986 to December 2013. Forty-four biopsies (4.9%) were inadequate, 490 …

We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic
immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and …

Background Health-related quality of life (HRQoL) impairment is often reported among
COVID-19 ICU survivors, and little is known about their long-term outcomes. We evaluated the …

Giant cell arteritis (GCA) is the most common form of vasculitis in individuals aged 50 years
and over. GCA typically affects large and medium-sized arteries, with a predilection for the …

This study evaluated the frequency, timing, and characteristics of flares in a large cohort of
Italian patients with biopsy-proven giant cell arteritis (GCA) and to identify factors at diagnosis …

Objective To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X‐linked,
autoinflammatory, somatic syndrome) from a single‐center cohort of Italian patients with vasculitis, …

The increasing availability and improvement of imaging techniques are making a profound
impact in the evaluation and management of patients with vasculitis, particularly for those …